Martina Brueckmann
Heart Failure / Cardiomyopathy
Boehringer Ingelheim (Germany)
About
Martina Brueckmann works in Heart Failure / Cardiomyopathy affiliated with Boehringer Ingelheim (Germany).
Martina Brueckmann, MD, is Head of Global Development Cardiovascular at Boehringer Ingelheim International GmbH in Ingelheim, Germany, and holds a faculty position at the University of Heidelberg/Mannheim. She is a cardiologist with prior clinical practice experience and extensive work in pharmaceutical clinical development, including leadership in trials for empagliflozin and other cardio-metabolic agents. She has authored or co-authored hundreds of peer-reviewed publications on heart failure, diabetes, and related cardiovascular topics.
Research focus
Empagliflozin in heart failure with preserved/reduced ejection fractionCardio-metabolic disease managementAtrial fibrillation outcomesDiabetes and cardiovascular risk reductionGlobal clinical development of cardiovascular therapies
Impact
221 pubs · 24,489 cites · h-index 58
Training
MD
Goethe University Frankfurt
1997
Affiliations
Work Experience
Head of Global Development Cardiovascular
Boehringer Ingelheim International GmbH · 2008 - Present
Associate Professor / Lecturer
University of Heidelberg / University of Mannheim